| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/16/1992 | CN1064409A 无细胞马立克氏病病毒疫苗 Marek's disease virus acellular vaccine |
| 09/16/1992 | CA2105965A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/15/1992 | WO1992016644A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | WO1992016643A1 Recombinant hybrid porin epitopes |
| 09/15/1992 | WO1992016627A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | WO1992016228A1 TGF-β1/β2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 09/15/1992 | US5147862 Administering a 1,3-glucan |
| 09/15/1992 | US5147639 Type-c rotavirus cultures and uses therefor |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/15/1992 | US5147637 Administering an anti-infective agent and a monoclonal antibody to reduce inflammation caused by meningitis or encephalitis |
| 09/15/1992 | US5147537 Carrier for affinity chromatography immobilized with antibodies |
| 09/15/1992 | US5147289 Non-specific immune system enhancement |
| 09/15/1992 | CA2106193A1 Means for in vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | CA2106093A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | CA2105877A1 Tgf-.beta.1/.beta.2: novel chimeric transforming growth factor-beta |
| 09/15/1992 | CA1307485C Protection of proteins and the like |
| 09/15/1992 | CA1307478C Methods and compositions for the identification of metastatic human tumors |
| 09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
| 09/13/1992 | WO1992016562A1 Humanised antibodies having modified allotypic determinants |
| 09/13/1992 | CA2105980A1 Humanised antibodies having modified allotypic determinants |
| 09/10/1992 | CA2062410A1 Recombinant proteins with the immunoreactivity of hepatitis b virus e antigen (hbeag), a process for the preparation thereof and the use thereof in immunoassays and vaccines |
| 09/09/1992 | WO1992015331A1 Lyophilized monoclonal antibody preparation |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502553A2 Peptide fragment from human villin and antibody thereto |
| 09/09/1992 | EP0502416A1 Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502105A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens |
| 09/09/1992 | EP0502100A1 Reduced-protein subunit vaccine for swine dysentery |
| 09/09/1992 | EP0502099A1 Chimeric proteins |
| 09/09/1992 | EP0190159B1 $i(IN VITRO) DETECTION OF GASTROINTESTINAL CANCER |
| 09/09/1992 | CN1064217A Pneumococcal polysaccharide conjugate vaccine |
| 09/09/1992 | CA2082169A1 Freeze-dried preparation containing monoclonal antibody |
| 09/08/1992 | US5145773 Contact with monoclonal antibodies to form antigen-antibody complex |
| 09/08/1992 | US5145676 Method and agents for promoting wound healing |
| 09/08/1992 | CA2037727A1 Removing lps pyrogen from aqueous solution |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/03/1992 | WO1992014823A1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
| 09/03/1992 | WO1992014704A1 2-substituted-2-imidazolines |
| 09/03/1992 | WO1992014489A1 Poliovirus-based vaccines |
| 09/03/1992 | WO1992014487A1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans |
| 09/03/1992 | WO1992014486A1 Transmission blocking vaccine against malaria |
| 09/03/1992 | WO1992014485A1 A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/02/1992 | WO1992015276A2 Therapeutic and cosmetic compositions for treatment of skin |
| 09/02/1992 | EP0501882A2 Method of anti LHRH immunoneutralization of non-castrated male animals and peptide therefore |
| 09/02/1992 | EP0501557A1 Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
| 09/02/1992 | EP0501321A1 Immunosuppressive drug containing an anti-estradiol antibody |
| 09/02/1992 | EP0501320A1 Immunopotentiating drug containing an anti-testosterone antibody |
| 09/02/1992 | EP0501233A1 Hybridomas and monoclonal antibodies that inhibit anti-CD3-stimulated T cell proliferation |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0500826A1 Apo ai polypeptides, antibodies, and immunoassays |
| 09/02/1992 | EP0500791A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 09/02/1992 | EP0500785A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 09/02/1992 | EP0500751A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
| 09/02/1992 | EP0500699A1 Cross-protective salmonella vaccines |
| 09/02/1992 | CA2062097A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 09/01/1992 | US5144008 Artificial carrier for immobilization of biological proteins |
| 09/01/1992 | US5143903 Method of treatment with tripeptide pharmaceutical compositions as immunomodulators |
| 09/01/1992 | US5143727 Method for preventing diarrhea |
| 09/01/1992 | US5143726 T cell epitopes of the hepatitis B virus nucleocapsid protein |
| 09/01/1992 | CA1306964C Method for the preparation of immunoglobulins suitable for intravenous administration |
| 09/01/1992 | CA1306961C Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins |
| 08/29/1992 | CA2104285A1 Recombinant fiv glycoprotein 160 and p24 gag protein |
| 08/27/1992 | WO1992014756A1 Therapeutically useful peptides and peptides fragments |
| 08/27/1992 | CA2061406A1 Immunosuppressive drug |
| 08/27/1992 | CA2061405A1 Immunopotentiating drug |
| 08/27/1992 | CA2059824A1 Hybridomas and monoclonal antibodies that inhibit anti-cd3-stimulated t cell proliferation |
| 08/26/1992 | EP0499834A2 A blood-stage antigen from Plasmodium falciparum, its preparation and use |
| 08/26/1992 | EP0499681A1 PCTD plasmid isolated form chlamydia trachomatis serotype D, its genes and proteins encoded by them; recombinant plasmids for the expression of said genes in heterologous systems as fused recombinant proteins, preparation of said recombinant proteins and their use in the formulation of vaccins and/or gianostics |
| 08/25/1992 | US5142032 Human papillomavirus type 41 dna |
| 08/25/1992 | US5142028 Can be used for elucidation of sugar chain roles in cell functions |
| 08/25/1992 | US5142027 Cationized carriers for immunogen production |
| 08/25/1992 | US5142025 Diagnosis, therapy aids |
| 08/25/1992 | US5141952 Heterocyclic dicarboxylic acids |
| 08/25/1992 | US5141876 Quatitative analysis of proteins in urine sampling by complexing with first antibodies and second antibodies with radioactive label |
| 08/25/1992 | US5141867 Nucleotide sequence encoding a human immunodeficiency virus antigen |
| 08/25/1992 | US5141864 Monoclonal antibody recognizing alpha 2→3 bonds |
| 08/25/1992 | US5141743 Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same |
| 08/25/1992 | US5141742 Pure p97 protein antigen from genetically engineered cultured cell; immunogens |
| 08/25/1992 | CA1306709C Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 |
| 08/25/1992 | CA1306707C Anti-human pulmonary adenocarcinoma specific monoclonal antibody |
| 08/25/1992 | CA1306706C Monoclonal antibodies to human gastrointestinal cancer |
| 08/25/1992 | CA1306691C Method of the virus-inactivating heat treatment of _-globulin and heat-treated aqueous solution containing the same |
| 08/25/1992 | CA1306690C Preparations active against pseudomonas aeruginosa infections and methods of producing them |
| 08/25/1992 | CA1306689C Method of preparing a vaccine against hepatitis b and the vaccine thus obtained |
| 08/25/1992 | CA1306678C Active specific immune suppression |
| 08/22/1992 | CA2061575A1 Plasmodium falciparum blood-stage antigen, the preparation and use thereof |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013950A2 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 08/20/1992 | WO1992013949A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/20/1992 | WO1992013948A1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family |
| 08/20/1992 | WO1992013947A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 08/20/1992 | WO1992013943A1 Herpes simplex virus-1 deletion variants and vaccines thereof |
| 08/20/1992 | WO1992013892A1 Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 08/20/1992 | WO1992013890A1 Nematode vaccine |